A citation-based method for searching scientific literature

Jinfang Zhu, Weiran Liu, Chen Chen, Hua Zhang, Dongsheng Yue, Chenguang Li, Lianmin Zhang, Liuwei Gao, Yansong Huo, Chang Liu, Giuseppe Giaccone, Bin Zhang, Changli Wang. J Cancer Res Clin Oncol 2019
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vaccination of patients with cutaneous melanoma with telomerase-specific peptides.
Robert E Hunger, Kristin Kernland Lang, Carrie J Markowski, Sissel Trachsel, Mona Møller, Jon A Eriksen, Anne-Marie Rasmussen, Lasse R Braathen, Gustav Gaudernack. Cancer Immunol Immunother 2011
31
100

ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres.
Adrian S Tong, J Lewis Stern, Agnel Sfeir, Melissa Kartawinata, Titia de Lange, Xu-Dong Zhu, Tracy M Bryan. Cell Rep 2015
72
100

A molecular model for drug binding to tandem repeats of telomeric G-quadruplexes.
Shozeb M Haider, Stephen Neidle. Biochem Soc Trans 2009
24
100

Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.
Reuben H Kim, Roy Kim, Wei Chen, Shen Hu, Ki-Hyuk Shin, No-Hee Park, Mo K Kang. Carcinogenesis 2008
31
100

Phosphatase and tensin homologue deleted on chromosome 10.
Imran Haruna Abdulkareem, Maria Blair. Niger Med J 2013
14
100


Targeting telomerase-expressing cancer cells.
Michel M Ouellette, Woodring E Wright, Jerry W Shay. J Cell Mol Med 2011
50
100

Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review.
Takahiro Eitsuka, Kiyotaka Nakagawa, Shunji Kato, Junya Ito, Yurika Otoki, Soo Takasu, Naoki Shimizu, Takumi Takahashi, Teruo Miyazawa. Int J Mol Sci 2018
14
100

Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.
Hua Zhou, Abdul Mondal, Aleksandra Dakic, Lama Alhawas, Xuefeng Liu, Zhixu He. Biomed Res Int 2018
3
100

Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
P Gu, Y Wang, K K Bisht, L Wu, L Kukova, E M Smith, Y Xiao, S M Bailey, M Lei, J Nandakumar,[...]. Oncogene 2017
28
100

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
100

Solid phase versus solution phase synthesis of heterocyclic macrocycles.
Seong Jong Kim, Shelli R McAlpine. Molecules 2013
8
100

XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.
Xiao-Hong Tian, Wei-Jian Hou, Yan Fang, Jun Fan, Hao Tong, Shu-Ling Bai, Qu Chen, He Xu, Yan Li. J Exp Clin Cancer Res 2013
73
100


RPA and POT1: friends or foes at telomeres?
Rachel Litman Flynn, Sandy Chang, Lee Zou. Cell Cycle 2012
20
100



The serial cultivation of human diploid cell strains.
L HAYFLICK, P S MOORHEAD. Exp Cell Res 1961
100

Telomerase as a Cancer Target. Development of New Molecules.
D L Mengual Gomez, R G Armando, C S Cerrudo, P D Ghiringhelli, D E Gomez. Curr Top Med Chem 2016
40
100

Biopharmaceutical characterization of the telomerase inhibitor BRACO19.
S Taetz, C Baldes, T E Mürdter, E Kleideiter, K Piotrowska, U Bock, E Haltner-Ukomadu, J Mueller, H Huwer, U F Schaefer,[...]. Pharm Res 2006
29
100

Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
Cheng-Le Zhuang, Xing Fu, Li Liu, Yu-Chen Liu, Wei-Ren Huang, Zhi-Ming Cai. Tumour Biol 2015
13
100

Inhibition of telomerase recruitment and cancer cell death.
Mai Nakashima, Jayakrishnan Nandakumar, Kelly D Sullivan, Joaquín M Espinosa, Thomas R Cech. J Biol Chem 2013
33
100

Telomeres at a glance.
Agnel Sfeir. J Cell Sci 2012
15
100

Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs.
Yuval Samuni, Hisanari Ishii, Fuminori Hyodo, Uri Samuni, Murali C Krishna, Sara Goldstein, James B Mitchell. Free Radic Biol Med 2010
54
100

The POT1-TPP1 telomere complex is a telomerase processivity factor.
Feng Wang, Elaine R Podell, Arthur J Zaug, Yuting Yang, Paul Baciu, Thomas R Cech, Ming Lei. Nature 2007
456
100

The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.
Jayakrishnan Nandakumar, Caitlin F Bell, Ina Weidenfeld, Arthur J Zaug, Leslie A Leinwand, Thomas R Cech. Nature 2012
200
100


Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition.
Oliver E Bechter, Ying Zou, William Walker, Woodring E Wright, Jerry W Shay. Cancer Res 2004
151
100

Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells.
Sutapa Chakraborty, Utpal Ghosh, N P Bhattacharyya, R K Bhattacharya, Madhumita Roy. Mutat Res 2006
73
100

Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Syed M Meeran, Shweta N Patel, Trygve O Tollefsbol. PLoS One 2010
216
100

The hsp90 molecular chaperone modulates multiple telomerase activities.
Oyetunji A Toogun, Diane C Dezwaan, Brian C Freeman. Mol Cell Biol 2008
61
100

Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Andrew M Rankin, Douglas V Faller, Remco A Spanjaard. Anticancer Drugs 2008
30
100


T-oligo as an anticancer agent in colorectal cancer.
Luke Wojdyla, Amanda L Stone, Nan Sethakorn, Srijayaprakash B Uppada, Joseph T Devito, Marc Bissonnette, Neelu Puri. Biochem Biophys Res Commun 2014
9
100


Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells.
Marzieh Nasiri, Nosratollah Zarghami, Kazem Nejati Koshki, Mahdieh Mollazadeh, Mohammad Pourhassan Moghaddam, Mohammad Rahmati Yamchi, Rana Jahanban Esfahlan, Amin Barkhordari, Abbas Alibakhshi. Asian Pac J Cancer Prev 2013
49
100

Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.
Christina Y Soohoo, Rong Shi, Tae Ho Lee, Pengyu Huang, Kun Ping Lu, Xiao Zhen Zhou. J Biol Chem 2011
29
100


Heat shock proteins and cancer: How can nanomedicine be harnessed?
Félix Sauvage, Samir Messaoudi, Elias Fattal, Gillian Barratt, Juliette Vergnaud-Gauduchon. J Control Release 2017
20
100

Telomerase and cancer therapeutics.
Calvin B Harley. Nat Rev Cancer 2008
467
100

The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells.
Nassima Temime-Smaali, Lionel Guittat, Assitan Sidibe, Kazuo Shin-ya, Chantal Trentesaux, Jean-François Riou. PLoS One 2009
51
100


Telomeres do D-loop-T-loop.
C W Greider. Cell 1999
148
100

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.
Tim F Greten, Alejandro Forner, Firouzeh Korangy, Gisele N'Kontchou, Nathalie Barget, Carmen Ayuso, Lars A Ormandy, Michael P Manns, Michel Beaugrand, Jordi Bruix. BMC Cancer 2010
128
100


Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
A Prasanth Saraswati, Nicola Relitti, Margherita Brindisi, Sandra Gemma, Daniela Zisterer, Stefania Butini, Giuseppe Campiani. Drug Discov Today 2019
15
100

hTERT-based therapy: a universal anticancer approach (Review).
Mu-Han Lü, Zhong-Li Liao, Xiao-Yan Zhao, Ya-Han Fan, Xian-Long Lin, Dian-Chun Fang, Hong Guo, Shi-Ming Yang. Oncol Rep 2012
27
100

Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.
Gaurav Garg, Anuj Khandelwal, Brian S J Blagg. Adv Cancer Res 2016
54
100

Getting in (and out of) the loop: regulating higher order telomere structures.
Sarah Luke-Glaser, Heiko Poschke, Brian Luke. Front Oncol 2012
12
100

In vivo stoichiometry of shelterin components.
Kaori K Takai, Sarah Hooper, Stephanie Blackwood, Rita Gandhi, Titia de Lange. J Biol Chem 2010
153
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.